DAMMACCO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1111
EU - Europa 260
AS - Asia 125
Totale 1496
Nazione #
US - Stati Uniti d'America 1110
CN - Cina 115
SE - Svezia 87
IT - Italia 54
UA - Ucraina 30
FI - Finlandia 22
DE - Germania 21
BE - Belgio 20
GB - Regno Unito 19
FR - Francia 5
IR - Iran 5
VN - Vietnam 4
CA - Canada 1
IN - India 1
ME - Montenegro 1
RU - Federazione Russa 1
Totale 1496
Città #
Chandler 146
Fairfield 143
Ann Arbor 117
Houston 106
Woodbridge 97
Jacksonville 69
Nyköping 68
Seattle 59
Cambridge 51
Wilmington 49
Ashburn 45
Beijing 42
Roxbury 27
Bari 26
Nanjing 26
Lawrence 23
Brussels 20
Inglewood 18
Des Moines 15
Princeton 14
Dearborn 9
Jiaxing 9
Boardman 8
Brooklyn 8
Nanchang 7
San Diego 7
San Mateo 7
Augusta 6
Changsha 6
Leawood 6
Monmouth Junction 6
Shenyang 6
Hebei 5
Ardabil 4
Dong Ket 4
Marseille 4
Tianjin 4
Lodi 3
Monza 3
Rome 3
Auburn Hills 2
Grafing 2
Ningbo 2
Ostuni 2
Taizhou 2
Chicago 1
Clearwater 1
Falkenstein 1
Haikou 1
Jinan 1
Kunming 1
Mumbai 1
Naples 1
Noicattaro 1
Ottawa 1
Paris 1
Podgorica 1
Qingdao 1
Redmond 1
Redwood City 1
Simi Valley 1
Wuppertal 1
Wuxi 1
Totale 1304
Nome #
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 112
Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques 100
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 97
Autoantibodies to intracellular antigens: generation and pathogenetic role 96
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 95
Goodpasture's disease: a report of ten cases and a review of the literature. 85
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 72
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 68
null 64
Ibridizzazione in situ non isotopica. Attualità e prospettive 59
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate 59
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia. 53
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides 50
null 47
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 45
Cancrini, Caterina, et al. "Clinical features and follow-up in patients with 22q11. 2 deletion syndrome." The Journal of pediatrics 164.6 (2014): 1475-1480. 41
null 41
null 39
Insight into the specificità of the anti-CD20 monclonal antibody Rituximab. 38
The proliferative transcriptional factor FOXE3 is the target of anti-CENP-A antibodies (Ab) and identifies a subset of anti-CENP Ab positive systemic sclerosis patients. 38
null 36
null 35
null 34
Membrane-type metalloprotease activity and HLA class I mRNA splicing in generating tFHC variants in multiple myeloma: clinical significance 32
null 30
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 23
Flogosis and Heart involvement in Large Vessel Vasculitis 19
null 17
Soluble CD4 and commercial immunoglobulins 16
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 13
Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression 10
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 8
Dendritic cells are recruited to the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T cell killing. 7
β2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 1
Totale 1580
Categoria #
all - tutte 3272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182 0000 00 00 0101
2018/2019166 6115 214 62 2314056
2019/2020365 69231124 3125 3023 41364210
2020/2021316 30152313 3412 3320 25316416
2021/2022201 1127116 77 817 8114147
2022/2023328 51562731 3547 638 37000
Totale 1580